1. Home
  2. ALK vs LEGN Comparison

ALK vs LEGN Comparison

Compare ALK & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALK
  • LEGN
  • Stock Information
  • Founded
  • ALK 1932
  • LEGN 2014
  • Country
  • ALK United States
  • LEGN United States
  • Employees
  • ALK N/A
  • LEGN N/A
  • Industry
  • ALK Air Freight/Delivery Services
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALK Consumer Discretionary
  • LEGN Health Care
  • Exchange
  • ALK Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • ALK 6.5B
  • LEGN 7.0B
  • IPO Year
  • ALK N/A
  • LEGN 2020
  • Fundamental
  • Price
  • ALK $50.35
  • LEGN $35.06
  • Analyst Decision
  • ALK Strong Buy
  • LEGN Strong Buy
  • Analyst Count
  • ALK 12
  • LEGN 13
  • Target Price
  • ALK $69.58
  • LEGN $79.17
  • AVG Volume (30 Days)
  • ALK 4.5M
  • LEGN 1.1M
  • Earning Date
  • ALK 04-17-2025
  • LEGN 03-11-2025
  • Dividend Yield
  • ALK N/A
  • LEGN N/A
  • EPS Growth
  • ALK 68.31
  • LEGN N/A
  • EPS
  • ALK 3.08
  • LEGN N/A
  • Revenue
  • ALK $11,735,000,000.00
  • LEGN $627,241,000.00
  • Revenue This Year
  • ALK $28.00
  • LEGN $66.60
  • Revenue Next Year
  • ALK $5.77
  • LEGN $49.28
  • P/E Ratio
  • ALK $16.34
  • LEGN N/A
  • Revenue Growth
  • ALK 12.55
  • LEGN 119.97
  • 52 Week Low
  • ALK $32.62
  • LEGN $30.17
  • 52 Week High
  • ALK $78.08
  • LEGN $60.87
  • Technical
  • Relative Strength Index (RSI)
  • ALK 28.53
  • LEGN 44.07
  • Support Level
  • ALK $51.41
  • LEGN $34.00
  • Resistance Level
  • ALK $55.33
  • LEGN $36.20
  • Average True Range (ATR)
  • ALK 2.02
  • LEGN 1.52
  • MACD
  • ALK 0.04
  • LEGN -0.25
  • Stochastic Oscillator
  • ALK 4.77
  • LEGN 25.18

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico, and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements (CPA). The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary and Mileage Plan passenger revenue.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: